5_Press release_ECL A2M TF Reaction to BMJ study Oct2017

About the author

You must be logged in to post a comment.

Bewaren

Registered office: Chaussée de Louvain 479
1030 Brussels, Belgium
Phone: +32 2 256 2000
Fax: +32 2 256 2003
mail us

EU quarters office:
ECL c/o Mundo-J
Rue de l’Industrie 10
1000 Bruxelles, Belgium

Transparency register no
19265592757-25

Co-funded by the European Union.

ECL has received funding under an operating grant (number: 101124367) from the EU4Health Programme (2021-2027).

Bewaren